Clinical Trials · NCT06659718
Emulation of the SOUL Diabetes Trial in Healthcare Claims
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 43,650
- Start date
- Oct 2024
- Locations
- 1 site, United States
- Primary endpoint
- Major adverse cardiac event (MACE), including myocardial infarction, stroke and all cause death